CLINICAL_TRIALS
trial_result
· 2018-04-25
Clinical Trial Update: STA-9090 in Patients With Advanced Hepatocellular Cancer [Phase 1]
Summary
A Phase 1 trial evaluating STA-9090 for advanced hepatocellular carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: COMPLETED